Changes in EGFR activity following CRISPR/Cas9-editing of the EGF binding domain

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Scientific Reports

• Publication date

  2026-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41598-026-37579-8PMID 41620519PMCID PMC12917122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Destruction of VISTA by TRIM25 ablation in T cells potentiates cancer immunotherapy

  2025cited by this paper
• Lysosomal EGFR acts as a Rheb-GEF independent of its kinase activity to activate mTORC1

  2025cited by this paper
• The EMBL-EBI Job Dispatcher sequence analysis tools framework in 2024

  2024cited by this paper
• Improving CRISPR–Cas9 directed faithful transgene integration outcomes by reducing unwanted random DNA integration

  2024cited by this paper
• Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes

  2024cited by this paper
• The HADDOCK2.4 web server for integrative modeling of biomolecular complexes

  2024influential reference
• Accurate structure prediction of biomolecular interactions with AlphaFold 3

  2024influential reference
• Harmonizome 3.0: integrated knowledge about genes and proteins from diverse multi-omics resources

  2024cited by this paper
• CRISPR/Cas9-induced DNA breaks trigger crossover, chromosomal loss, and chromothripsis-like rearrangements

  2023cited by this paper
• EGFR endocytosis: more than meets the eye

  2023cited by this paper
• EGFR trafficking: effect of dimerization, dynamics, and mutation

  2023cited by this paper
• Ten Years of CRISPRing Cancers In Vitro

  2022cited by this paper
• Elevated expression of exogenous RAD51 enhances the CRISPR/Cas9-mediated genome editing efficiency

  2022cited by this paper
• EGFR signaling pathway as therapeutic target in human cancers.

  2022influential reference
• Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells—EGFRvIII Appears as a Weak Oncogene

  2022influential reference
• Structural Biology in the Clouds: The WeNMR-EOSC Ecosystem

  2021influential reference
• CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation

  2020cited by this paper
• Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors.

  2020cited by this paper
• EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells.

  2020cited by this paper
• Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing

  2020cited by this paper
• Targeted therapy in cervical cancer

  2019cited by this paper
• Expression of epidermal growth factor receptor in squamous cell carcinoma of uterine cervix

  2019influential reference
• Cell Model Passports—a hub for clinical, genetic and functional datasets of preclinical cancer models

  2018cited by this paper
• CRISPR therapeutic tools for complex genetic disorders and cancer (Review)

  2018cited by this paper
• Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements

  2018cited by this paper
• AACR Project GENIE: Powering Precision Medicine through an International Consortium.

  2017cited by this paper
• EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics.

  2017cited by this paper
• Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways

  2017influential reference
• The BioStudies database—one stop shop for all data supporting a life sciences study

  2017cited by this paper
• PRODIGY: A Contact-based Predictor of Binding Affinity in Protein-protein Complexes.

  2017cited by this paper
• The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins

  2016cited by this paper
• The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor Family

  2016cited by this paper
• CRISP-ID: decoding CRISPR mediated indels by Sanger sequencing

  2016cited by this paper
• EGF receptor ligands: recent advances

  2016cited by this paper
• PRODIGY: a web server for predicting the binding affinity of protein-protein complexes

  2016cited by this paper
• Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis

  2016cited by this paper
• Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications

  2015cited by this paper
• Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery

  2014cited by this paper
• EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4.

  2014cited by this paper
• EGF receptor trafficking: consequences for signaling and cancer

  2014cited by this paper
• The ErbB/HER family of protein-tyrosine kinases and cancer.

  2014cited by this paper
• When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling

  2013cited by this paper
• P27 as a Prognostic Factor of Early Cervical Carcinoma

  2013cited by this paper
• Individual karyotypes at the origins of cervical carcinomas

  2013cited by this paper
• The Genomic and Transcriptomic Landscape of a HeLa Cell Line

  2013cited by this paper
• The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered

  2013cited by this paper
• EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.

  2013influential reference
• A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff

  2012cited by this paper
• Epidermal growth factor receptor as a biomarker for cervical cancer.

  2011cited by this paper
• Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study.

  2011cited by this paper
• Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain

  2011cited by this paper
• Tumor suppressor FOXO3 mediates signals from the EGF receptor to regulate proliferation of colonic cells.

  2011cited by this paper
• Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654

  2010cited by this paper
• The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1).

  2010cited by this paper
• Functional proteomics to dissect tyrosine kinase signalling pathways in cancer

  2010cited by this paper
• A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

  2009cited by this paper
• Radiation-induced lipid peroxidation activates src kinase and triggers nuclear EGFR transport.

  2009cited by this paper
• Ultraviolet irradiation‐induces epidermal growth factor receptor (EGFR) nuclear translocation in human keratinocytes

  2009cited by this paper
• All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells

  2008cited by this paper
• Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells.

  2008cited by this paper
• A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.

  2008cited by this paper
• Molecular profiling of cervical cancer progression

  2007cited by this paper
• Molecular analysis of the PI3K‐AKT pathway in uterine cervical neoplasia: Frequent PIK3CA amplification and AKT phosphorylation

  2006cited by this paper
• Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: Report from a phase I/II trial

  2006cited by this paper
• Radiation-induced Epidermal Growth Factor Receptor Nuclear Import Is Linked to Activation of DNA-dependent Protein Kinase*

  2005cited by this paper
• Evolution of distinct EGF domains with specific functions

  2005cited by this paper
• Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.

  2004cited by this paper
• Transgenic and knock-out mice for deciphering the roles of EGFR ligands

  2003cited by this paper
• Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.

  2002influential reference
• A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma.

  2002cited by this paper
• Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells.

  1997cited by this paper
• Epidermal Growth Factor Receptor Expression and the Presence of Human Papillomavirus in Cervical Squamous Intraepithelial Lesions

  1992cited by this paper
• Functional analysis of the ligand binding site of EGF‐receptor utilizing chimeric chicken/human receptor molecules.

  1989cited by this paper
• A novel effect of EGF on mRNA stability.

  1988cited by this paper
• A transcription factor active on the epidermal growth factor receptor gene.

  1988cited by this paper
• Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas.

  1986cited by this paper
• Epidermal growth factor regulates the expression of its own receptor.

  1985cited by this paper
• Genetic analysis of epidermal growth factor action: assignment of human epidermal growth factor receptor gene to chromosome 7.

  1980cited by this paper

• No citing papers are available for this paper.